You have to be logged in to add this to Watchlist.Kilitch Drugs India is trading -0.31% lower at Rs 324.00 as compared to its last closing price. Kilitch Drugs India has been trading in the price range of 325.00 & 322.10. Kilitch Drugs India has given 106.87% in this year & -0.92% in the last 5 days.
Kilitch Drugs India has TTM P/E ratio 28.03 as compared to the sector P/E of 24.29.There are 1 analysts who have initiated coverage on Kilitch Drugs India. There are 1 analysts who have given it a strong buy rating & 0 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 4.74 Crores in its last quarter.
Listed peers of Kilitch Drugs India include Albert David (-0.95%), Zim Laboratories (1.21%), Kilitch Drugs India (-0.31%) etc.
Kilitch Drugs India has a 69.23% promoter holding & 30.77% public holding. The FII holding in Kilitch Drugs India was at 0.03% in 31 Dec 2021. The FII holding has - from the last quarter.
Kilitch Drugs India share price range
|
| ||||
|
| ||||
Kilitch Drugs India share Key Metrics
| Market Cap ( ₹ Cr.) | 517.85 | ||||||||||||||||||
|
|
Kilitch Drugs India share price news
Multibagger small-cap stock hits upper circuit on two days in a row after Q4 results
2 min read .12:56 PM ISTKilitch Drugs India Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 09-Nov-23 | Quarterly Results |
| 11-Aug-23 | Quarterly Results |
| 22-Jul-23 | Others |
| 29-May-23 | Audited Results |
| 14-Feb-23 | Quarterly Results |
| 14-Nov-22 | Quarterly Results |
| 10-Aug-22 | Quarterly Results |
| 26-May-22 | Audited Results |
| 14-Feb-22 | Quarterly Results |
| 12-Nov-21 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 11-Apr-23 | 16-Mar-23 | EGM |
FAQs about Kilitch Drugs India share price
Kilitch Drugs India is trading at 324.00 as on Wed Nov 29 2023 09:45:00. This is -0.31% lower as compared to its previous closing price of 325.00.
The market capitalization of Kilitch Drugs India is 521.07 Cr as on Wed Nov 29 2023 09:45:00.
The average broker rating on Kilitch Drugs India is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 0 analysts have given a buy rating
- 0 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Kilitch Drugs India is 336.80 whereas the 52 wk low is 121.30
Kilitch Drugs India can be analyzed on the following key metrics -
- TTM P/E: 28.03
- Sector P/E: 24.29
- Dividend Yield: 0.00%
- D/E ratio: 0.17
Kilitch Drugs India reported a net profit of 10.45 Cr in 2023.
Kilitch Drugs India Quick Links
Kilitch Drugs India Dividend | Kilitch Drugs India Bonus | Kilitch Drugs India News | Kilitch Drugs India AGM | Kilitch Drugs India Rights | Kilitch Drugs India Splits | Kilitch Drugs India Board Meetings | Kilitch Drugs India Key Metrics | Kilitch Drugs India Shareholdings | Kilitch Drugs India Profit Loss | Kilitch Drugs India Balance Sheet | Kilitch Drugs India Cashflow | Kilitch Drugs India Q1 Results | Kilitch Drugs India Q2 Results | Kilitch Drugs India Q3 Results | Kilitch Drugs India Q4 Results
Equity Quick Links
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks
